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We investigated the cross-sectional and longitudinal effects of tobacco smoking on brain
atrophy in a large cohort of healthy elderly participants (65–80 years). MRI was used for
measuring whole brain (WB), gray matter (GM), white matter (WM), and hippocampus
(HIP) volumes at study entry time (baseline, N = 1451), and the annualized rates of
variation of these volumes using a 4-year follow-up MRI in a subpart of the cohort
(N = 1111). Effects of smoking status (never, former, or current smoker) at study entry
and of lifetime tobacco consumption on these brain phenotypes were studied using
sex-stratified AN(C)OVAs, including other health parameters as covariates. At baseline,
male current smokers had lower GM, while female current smokers had lower WM.
In addition, female former smokers exhibited reduced baseline HIP, the reduction being
correlated with lifetime tobacco consumption. Longitudinal analyses demonstrated that
current smokers, whether men or women, had larger annualized rates of HIP atrophy, as
compared to either non or former smokers, independent of their lifetime consumption
of tobacco. There was no effect of smoking on the annualized rate of WM loss. In all
cases, measured sizes of these tobacco-smoking effects were of the same order of
magnitude than those of age, and larger than effect sizes of any other covariate. These
results demonstrate that tobacco smoking is a major factor of brain aging, with sex- and
tissue specific effects, notably on the HIP annualized rate of atrophy after the age of 65.
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INTRODUCTION
With the aging of the general population and the associated eco-
nomical and social burden of age-related disorders, it has become
critical to characterize normal brain aging and to identify and
quantify factors that may accelerate brain aging and/or lead to
age-related neurological disorders. Brain tissue volumes, whether
global or regional (notably hippocampus), are endophenotypes
easily derivable from magnetic resonance imaging (MRI) that
have been shown to be sensitive to aging and good predictors of
dementia and cognitive decline in elderly individuals (Miller et al.,
1980; Braak and Braak, 1998; Good et al., 2001; Den Heijer et al.,
2002; Fjell and Walhovd, 2010). Using such brain phenotypes,
many studies have investigated factors of morphological brain
aging such as sex (Coffey et al., 1998; Resnick et al., 2003; Lemaître
et al., 2005b; Abe et al., 2010; Hua et al., 2010; O’Dwyer et al.,
2012; Ryan et al., 2014), genetics (Lemaître et al., 2005a; Crivello
et al., 2010; Boada et al., 2012; Stein et al., 2012; Ryan et al., 2014)
or lifestyle (Coffey et al., 1999; Sabia et al., 2014; Shpanskaya et al.,
2014; Umene-Nakano et al., 2014). Others have demonstrated the
effect on brain atrophy of cardiovascular risk factors such as obe-
sity (Driscoll et al., 2012; Xu et al., 2013; Debette et al., 2014, 2011;
Franke et al., 2014), hypertension (Debette et al., 2011; Maillard
et al., 2012; Peters, 2012; Beauchet et al., 2013; Franke et al., 2014),
hypercholesterolemia (Tendolkar et al., 2012; Van Velsen et al.,
2013; Franke et al., 2014), diabetes (Biessels et al., 2005; Debette
et al., 2011; Cherbuin et al., 2012; Franke et al., 2014) and tobacco
smoking (Enzinger et al., 2005; Ikram et al., 2008; Debette et al.,
2011; Durazzo et al., 2012; Hoogendam et al., 2012).
Regarding the last factor, its effects on brain atrophy has
recently received increased attention (Almeida et al., 2011;
Durazzo et al., 2012, 2013; Pan et al., 2013; Fritz et al., 2014)
because the consensus has been growing over the past years on
the fact that it should be considered as a brain aging enhancer
(Bernhard et al., 2007; Debette et al., 2011) and a risk factor for
cognitive decline (Ott et al., 2004; Anstey et al., 2007; Starr et al.,
2007; Sabia, 2012) and dementia (Ott et al., 1998; Anstey et al.,
2007; Rusanen et al., 2011). RecentMRI studies have so looked for
associations between tobacco consumption and either brain tissue
global volumes (Enzinger et al., 2005; Ikram et al., 2008; Debette
et al., 2011; Durazzo et al., 2012; Hoogendam et al., 2012), tis-
sue local density (Brody et al., 2004; Gallinat et al., 2006; Almeida
et al., 2008; Liao et al., 2010; Yu et al., 2011; Zhang et al., 2011;
Morales et al., 2012), or white matter integrity (Paul et al., 2008;
Debette et al., 2011; Umene-Nakano et al., 2014).
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However, a solid consensus has not yet been reached for any of
these morphological outcomes. Regarding global brain volumes,
for instance, some authors have reported enhanced reduction (or
accelerated rate of loss) of whole brain volume (WB, Ikram et al.,
2008; Debette et al., 2011; Hoogendam et al., 2012), while others
described no reduction or no accelerated rate of loss (Enzinger
et al., 2005; Durazzo et al., 2012). As for gray matter (GM)
regional densities, a meta-analysis of seven studies (Pan et al.,
2013) found that a reduction in the anterior cingulate cortex
of smokers was the only robust finding. Similar discrepancy in
results were observed regarding white matter (WM) integrity,
some showing reduced WM integrity in smokers compared to
non-smokers (Debette et al., 2011; Umene-Nakano et al., 2014)
while another study showed increased WM integrity in smokers
(Paul et al., 2008).
Such discrepancies are likely to come from multiple sources,
starting with small sample sizes, especially of current smokers,
when dealing with cohorts of elderly, leading some studies to pool
current and former smokers in their analyses while others did not.
It must also be stressed that voxel-based studies are intrinsically
subject to reduced statistical power given the very large number
of brain phenotypes simultaneously analyzed. Another potential
source of discrepancy is the choice of whole brain volume as a
phenotype of interest. Indeed, gray and white matters have differ-
ent dynamics during development, maturation and aging (Miller
et al., 1980; Smith et al., 2007; Abe et al., 2010). Moreover, those
two tissues have a highly different cellular and vascular com-
position, leaving the possibility of differential susceptibility to
tobacco smoking, and calling for including gray and white vol-
umes as additional phenotypes of interest. Finally, another factor
that could lead to discrepancies is sex. There is evidence of sex-
ual dimorphism in brain aging (Coffey et al., 1998; Good et al.,
2001; Thambisetty et al., 2010), but few studies have searched for
sex-related effects on brain atrophy of cardiovascular risk factors,
and particularly of tobacco smoking. In addition, it should be
noted that GM and WM have different relative volumes in men
and women (Allen et al., 2003; Lemaître et al., 2005b; Leonard
et al., 2008), which could generate discrepancies between studies
having samples of different sex ratio and using WB as a phe-
notype of interest (see above). More generally, sex is a potential
confounding factor in studies on factors of brain aging because
men and women differed on many lifestyle and health parameters
potentially affecting brain atrophy, and notably on tobacco smok-
ing parameters with a larger frequency and lifetime consumption
in men.
The goal of the present study was thus to take advantage of a
large longitudinal community cohort study, the Three-City Study
(3C Study; Alpérovitch et al., 2002), for quantifying tissue- and
sex-specific effects of tobacco smoking on brain atrophy and to
compare them to effects of other known factors of brain aging.
An additional feature of this study is that, thanks to the longitu-
dinal study design, we were able to estimate the tobacco smoking
effects on brain atrophy both in the cross-sectional study sample
and in the subsample that underwent a follow-up examination
4 years after their entry in the study. The combination of the
cross-sectional and longitudinal approaches, implemented only
in a few previous studies on the same topic (Enzinger et al., 2005;
Durazzo et al., 2012) gave the opportunity to look at complemen-
tary aspects of tobacco smoking effects on brain atrophy, namely
lifetime cumulative effects and effects on the brain of elderly
individuals.
METHODS
POPULATION AND STUDY DESIGN
The 3C Study is a prospective cohort study, whose design has been
described in detail elsewhere (Alpérovitch et al., 2002). The study
took place in three French cities; here we use the subsample from
the city of Dijon (3C-D). Briefly, 4931 non-institutionalized per-
sons aged 65 years and over were recruited from the electoral rolls
of the city of Dijon between March 1999 and March 2001. The
Ethic committee of the Kremlin-Bicêtre hospital approved the
3C protocol, and all participants were asked to sign an informed
consent. 3C-Dijon participants enrolled between June 1999 and
September 2000, aged less than 80 years, those who were able
to come to the examination center (n = 2763) being invited to
have a brain MRI. Although 2285 persons agreed to participate,
because of financial limitations, 1924 participants were scanned
(3C-D-MRI subsample). As compared to participants who were
not scanned, the 3C-D-MRI sample was younger (72.5 vs. 73.4
years old, p < 0.001), and had a lower proportion of women
(62.2% vs. 71.0%, p < 0.001), higher education (high school
graduates: 23.5% vs. 17.8%, p < 0.001), and better health sta-
tus (62.3% vs. 56.4%, p < 0.001). Approximately 4 years after
inclusion, 1402 of those who were scanned agreed to have a
follow-up MRI (follow-up rate = 77.8%). A number of partici-
pants were later excluded due to either (1) poor technical quality
of their MRI, (2) failure in MRI processing, (3) missing data
(demographic, biological, cognitive, genotyping), or (4) previ-
ous history of stroke or a diagnosis of dementia according to
the DSM-IV criteria (American Psychiatric Association, 1994).
As a result, the sample of the present study eventually included
1451 participants at entry (920 women, 531 men) and 1111
participants at follow-up (721 women, 390 men).
MRI ACQUISITION AND PROCESSING
MRI examinations at study entry (tE) and 4 years follow-up (tF)
were acquired using the same scanner (1.5 T Siemens) and a
standardized acquisition imaging protocol. High-resolution T1-
weighted brain volume was acquired using a 3D inversion recov-
ery fast spoiled-gradient echo sequence (3D SPGR; TR = 9.7ms;
TE = 4ms; TI = 600ms; coronal acquisition). The axially reori-
ented 3D T1 volume matrix size was 256 × 192 × 256mm3,
with a voxel size of 1.0 × 0.98 × 0.98mm3. T2- and proton den-
sity (PD)-weighted brain volumes were acquired using a 2D fast
spin echo sequence with two echo times (TE1 = 16ms, TE2 =
98ms, TR = 4400ms). T2 and PD acquisitions consisted of 35
axial slices with 3.5mm thickness (0.5mm gap), 256 × 256mm2
matrix size and pixel size of 0.98 × 0.98mm2.
T1- and T2-weighted images of each participant were pro-
cessed with SPM99, an optimized Voxel-Based Morphometry
(VBM) protocol (Ashburner and Friston, 2000) that we cus-
tomized in order to take into account the structural characteristics
of the aged brain (Lemaître et al., 2005b). Using this VBM pro-
cedure, brain tissue probability maps were obtained for each
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individual and each acquisition time. We applied a modula-
tion step to each individual’s tissue probability density maps to
preserve the participant original tissue quantity after being trans-
ferred to the reference space used (Good et al., 2001). At tE and
tF , both gray matter (GM) white matter (WM) global volumes
were estimated as the integral of voxel intensities over their modu-
lated probability density images. At each time, whole brain (WB)
volume was computed as the sum of GM and WM volumes.
For the purpose of the present study, the hippocampus was
considered as a region of specific interest (ROI) given that it
is a highly recognized imaging marker of brain aging (Hof and
Morrison, 2004). Similar to previous studies (Lemaître et al.,
2005b; Crivello et al., 2010) left and right hippocampus volumes
were automatically estimated by integrating the voxel intensities
of the modulated GM partition images within hippocampus lim-
its as defined by the AAL atlas (Tzourio-Mazoyer et al., 2002).
Statistical analysis was performed on the total hippocampus
volume (HIP), i.e., on sum of the left and right volumes.
For the longitudinal analysis, we computed for each individ-
ual and each tissue (WB, GM, WM) and ROI (HIP), an annual
rate of volume change as: V = (VF − VE)/(tF − tE),VE and
VF being the estimated volumes at entry and 4 year follow-up,
respectively.
In this study, we did not correct the WM volume for the pres-
ence of WM lesions (WML). Rather, WML were evaluated at
entry for each participant using a multi-spectral (T1, T2, PD)
MRI analysis as previously reported (Maillard et al., 2008) and
used, as previously done by others (Enzinger et al., 2005; Ikram
et al., 2008; Durazzo et al., 2012; Hoogendam et al., 2012), as
a covariate in the statistical analysis of tobacco effect on brain
tissue.
TOBACCO SMOKING VARIABLES AND OTHER PERSONAL
HEALTH-RELATED COVARIATES
Participant status regarding tobacco consumption was catego-
rized as never, former and current smoker. Lifetime tobacco
consumption was estimated in number of “pack-years,” i.e., the
average number of packs of cigarettes smoked per day times the
number of years of smoking.
Consumption of alcohol was measured used in g/day of pure
alcohol. Systolic and diastolic blood pressure (SBP and DBP,
respectively), fasting blood glucose and total cholesterol were
measured in each individual. Hypertension was defined by sys-
tolic blood pressure (SBP) ≥140mm Hg, or diastolic blood
pressure (DBP) ≥90mm Hg, or use of antihypertensive drugs.
Diabetesmellitus was defined as fasting blood glucose≥7mmol/L
or use of anti-diabetic drugs. Hypercholesterolemia was defined
as fasting total cholesterol ≥6.2mmol/L or use of lipid-lowering
drugs. Body mass index (BMI) was calculated as the ratio of
weight (kg) to the square of height (m2).
Educational level was defined as the number of years of
scholarship since primary school. Participant’s global cognitive
status was evaluated using the Mini Mental State Examination
(Folstein et al., 1975). Depression symptoms were evaluated using
the Center for Epidemiologic Studies-Depression scale (CES-D).
Genotyping of the ApoE epsilon allele polymorphism was per-
formed as previously described (Crivello et al., 2010), participants
being classified as either non-carrier or carrier of an epsilon-4
allele.
STATISTICAL ANALYSIS
Statistical analysis was conducted separately in men and women
in order to avoid the confounding effects of sex on brain atrophy
and smoking. Effects of tobacco smoking status on brain tissue
volumes (WB, GM, WM, and HIP) at entry in the study or their
annualized variation were studied using general linear model-
ing. The cross-sectional sample was used for the analysis at study
entry time and the longitudinal sample for the analysis of annu-
alized tissue volume variations. Age, educational level, MMSE
score, BMI, CES-D score, SBP, DBP, fasting blood glucose, choles-
terolemia, alcohol consumption, WML, and Apo-ε4 charge were
included as covariates. Total intracranial volume (TIV) was used
as a covariate for WB, GM, and WM volumes analyses, whereas
GM tissue volume was used as a covariate for HIP volume analysis
in order to uncover effects that might be specific to this brain area
as compared to the rest of GM. Whenever a significant effect of
smoking status on a volume or annualized change was found, we
searched for a possible “dose-effect” through linear modeling of
this tissue volume/annualized change with pack-years as the inde-
pendent variable, and including the same set of covariates. For the
sake of comparison with previous studies, we performed an addi-
tional analysis on the entire sample including a sex main effect
and a sex by smoking interaction effect. In all statistical analy-
ses, variables (both dependent or independent) were standardized
allowing a comparison of the size of effects of the different inde-
pendent variables. All statistical analyses were performed using
the JMP Pro software (SAS Institute Inc., Cary, USA).
RESULTS
SAMPLE CHARACTERISTICS
Table 1 gives the bio-clinical characteristics of the cross-sectional
and longitudinal study samples separately for men and women.
At both entry and follow-up time, men and women differed on
all variables except age and MMSE. Men were better educated,
had higher fasting blood glucose, blood pressure, BMI, tobacco
smoking and alcohol intake, and lower CES-D score and choles-
terol level than women. Note, in particular, the marked difference
in the frequencies of never smokers in men (30.5%) and women
(82.4%).
Participants of the cross-sectional sample who did not have a
follow-up differed from those of the longitudinal sample on sev-
eral parameters: they were older at their entry in the study (73.2
vs. 72.0 years, p = 0.004 for men and 74.1 vs. 72.3 years, p < 10−4
for women), had a lower education level (6.6 vs. 10.3 years in men
and 5.6 vs. 8.9 years in women, p < 10−4 in both sexes), larger
CES-D scores (8.9 vs. 7.1, p = 0.009 in men and 13.0 vs. 11.3, p =
0.026 in women) and lower MMSE (27.5 vs. 27.8, p = 0.042 in
men and 27.3 vs. 27.7, p = 0.006 in women). Moreover in women
they also differed for BMI (25.6 vs. 24.7 kg/m2, p = 0.005) and
glycaemia (5.1 vs. 4.9mmol/l, p = 0.039).
Table 2 describes the smoking history parameters of male
and female former and current smokers, in the cross-sectional
and longitudinal samples. Besides the above-mentioned differ-
ence in smoking status frequencies, men and women also differed
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Table 1 | Bio-clinical characteristics of the women and men subgroups of participants at the time of entry in the cross-sectional and
longitudinal studies.
Cross-sectional study sample Longitudinal study sample
Men Women p Men Women p
Sample size 531 920 390 721
Age (years) 72.3 (4.00) 72.7 (4.06) 0.097 72.0 (3.93) 72.3 (3.93) 0.27
Education (years) 9.3 (4.8) 8.2 (4.4) <10−4 10.3 (4.6) 8.9 (4.2) <10−4
Smoking status <10−4 <10−4
non 162 (30.5%) 758 (82.4%) 118 (30.3%) 596 (82.7%)
former 320 (60.3%) 128 (13.9%) 235 (60.2%) 99 (13.7%)
current 49 (9.2%) 34 (3.7%) 37 (9.5%) 26 (3.6%)
Alcohol intake (g/day) 20.7 (16.1) 7.37 (8.27) <10−4 21.0 (16.5) 7.28 (8.23) <10−4
BMI (kg.m−2) 25.9 (3.25) 24.9 (3.90) <10−4 25.8 (3.08) 24.7 (3.72) <10−4
Fasting blood glucose (mmol/L) 5.26 (1.17) 4.97 (1.14) <10−4 5.29 (1.26) 4.93 (0.95) <10−4
Diabetes 10.2% 6.1% 0.014 11.0% 5.8% 0.008
SBP (mm Hg) 155.8 (21.7) 144.8 (22.2) <10−4 156.2 (21.4) 144.3 (22.0) <10−4
DBP (mm Hg) 87.9 (11.3) 83.3 (11.4) <10−4 88.3 (11.1) 83.3 (11.0) <10−4
Hypertension 83.2% 72.5% <10−4 83.0% 70.9% <10−4
Fasting blood cholesterol (mmol/L) 5.58 (0.90) 5.91 (0.94) <10−4 5.57 (0.90) 5.89 (0.93) <10−4
Hypercholesterolemia 33.7% 40.9% 0.006 35.9% 41.2% 0.085
ApoE-ε4 genotype 0.05 0.088
non carrier 403 (76.0%) 747 (81.2%) 297 (76.2%) 587 (81.4%)
carrier 128 (24.1%) 173 (18.8%) 93 (23.8%) 134 (18.6%)
CES-D 7.63 (6.9) 11.7 (9.4) <10−4 7.2 (6.4) 11.4 (9.2) <10−4
MMSE 27.77 (1.65) 27.67 (1.81) 0.36 27.85 (1.56) 27.76 (1.76) 0.36
WML (% of WM volume) 2.25 (1.72) 2.14 (1.93) 0.30 2.21 (1.75) 2.09 (1.95) 0.32
Values are means (standard deviations) or percentages. P is for the comparison between men and women (Student’s t-tests or Chi-squared tests). BMI, body mass
index; SBP and DBP, systolic and diastolic blood pressures; CES-D, Center for epidemiological study depression scale; MMSE, mini-mental scale examination. WML,
white matter lesion as a percentage of white matter (WM) volume.
Table 2 | Smoking history of former and current smokers in the baseline and follow-up samples.
Cross-sectional study sample Longitudinal study sample
Men Women Men Women
Former Current Former Current Former Current Former Current
Age when smoking start 18.9 (4.0) 19.2 (5.3) 23.2 (7.4) 24.1 (9.5) 18.7 (4.0) 19.4 (5.9) 23.2 (7.6) 21.6 (7.8)
Age when smoking quit 46.3 (13.0) n.a. 46.9 (13.6) n.a. 46.1 (12.5) n.a. 47.3 (14.1) n.a.
Years of smoking 27.4 (13.3) 51.1 (12.5) 23.7 (14.0) 48.2 (10.4) 27.3 (12.7) 52.4 (7.0) 24.1 (14.2) 50.6 (8.9)
Years free of smoking 25.9 (12.5) n.a. 25.1 (13.8) n.a. 26.0 (12.4) n.a. 24.5 (13.8) n.a.
Smoked pack-years 21.4 (18.4) 35.6 (20.2) 15.2 (23.5) 29.0 (18.8) 21.5 (12.5) 33.5 (21.7) 15.3 (24.3) 29.3 (17.3)
Values are means (standard deviations) at the time of participant entry in the study. “Pack-years” are the number of packs of cigarettes smoked per day times the
number of years of smoking.
regarding the age at which they started smoking (men start-
ing 4 years earlier than women, p < 10−4 for former smokers
and p = 0.0037 for current smokers). Regarding former smok-
ers, men smoked 3 years more than women, p = 0.009) and had
a higher lifetime tobacco consumption, consuming 6 pack-years
more than women (p = 0.0037). Such differences between men
and women were not observed in current smokers (p = 0.27 and
p = 0.14, respectively). Note that the most important differences
were between the former and current smoker groups in both
sexes, both in term of number of years of smoking (p < 10−4
for both sexes) and number of pack-years (p < 10−4 for men and
p = 0.0019 in women).
Average brain phenotypes derived from MRI are shown
in Table 3. At entry, cross-sectional and longitudinal samples
slightly differed regarding HIP volume in men (p = 0.001), and
WB (p = 0.022), GM (p = 0.0007) and HIP (p < 10−4) volumes
in women. As expected, men exhibited larger TIV, WB, GM,
WM, and HIP volumes than women both at entry and follow-up
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Table 3 | MRI-derived brain phenotypes of the men and women subgroups of participants at entry and follow-up (about 4 years after their
entry in the study), and their annual variation.
Cross-sectional sample Longitudinal sample Longitudinal sample Longitudinal sample
At entry At entry At follow-up Annual variation
Men Women Men Women Men Women Men Women p
TIV 1462 (116) 1297 (94) 1462 (111) 1294 (94) 1460 (111) 1291 (94) −0.48 (1.25) −0.73 (1.03) 0.0003
nS 1484 (122) 1297 (98) 1491 (114) 1293 (93) 1489 (114) 1290 (93) −0.56 (1.08) −0.76 (1.05) 0.061
fS 1450 (114) 1293 (102) 1446 (110) 1290 (96) 1445 (111) 1288 (96) −0.41 (1.35) −0.58 (0.91) 0.27
cS 1463 (100) 1317 (125) 1471 (91) 1330 (118) 1469 (90) 1328 (118) −0.61 (1.15) −0.59 (0.90) 0.95
WB 1043 (86) 937 (76) 1046 (88) 940 (76) 1028 (86) 921 (73) −5.00 (3.06) −5.34 (2.92) 0.068
nS 1062 (89) 937 (75) 1070 (91) 940 (74) 1052(90) 921 (72) −5.13 (2.73) −5.38 (2.89) 0.37
fS 1036 (86) 933 (78) 1033 (87) 935 (75) 1016 (86) 918 (72) −4.73 (2.95) −4.88 (3.05) 0.67
cS 1032 (67) 942 (86) 1045 (65) 952 (91) 1023 (61) 930 (93) −6.32 (4.24) −6.14 (3.02) 0.86
GM 539 (46) 489 (42) 540 (47) 492 (42) 527 (45) 476 (40) −3.63 (3.27) −4.49 (2.98) <10−4
nS 548 (50) 489 (41) 553 (50) 492 (41) 539 (50) 475 (40) −3.81 (3.06) −4.52 (2.94) 0.018
fS 535 (45) 490 (46) 535 (45) 492 (45) 522 (44) 477 (41) −3.43 (3.25) −4.19 (3.27) 0.054
cS 531 (36) 495 (50) 535 (37) 501 (54) 519 (33) 483 (55) −4.33 (3.92) −4.94 (2.78) 0.50
WM 505 (48) 447 (42) 506 (49) 447 (42) 500 (48) 445 (41) −1.37 (2.26) −0.85 (2.20) 0.0002
nS 514 (47) 448 (43) 517 (48) 449 (42) 513 (49) 446 (41) −1.31 (2.33) −0.86 (2.21) 0.044
fS 501 (49) 443 (40) 499 (49) 443 (38) 494 (49) 441 (39) −1.30 (2.21) −0.70 (2.21) 0.024
cS 502 (41) 446 (44) 510 (39) 451 (46) 504 (38) 447 (49) −1.99 (2.27) −1.21 (1.85) 0.15
HIP 7.01 (0.84) 6.40 (0.73) 7.08 (0.83) 6.46 (0.72) 6.84 (0.87) 6.20 (0.78) −0.066 (0.069) −0.071 (0.062) 0.17
nS 7.11 (0.85) 6.41 (0.73) 7.21 (0.84) 6.46 (0.72) 6.97 (0.88) 6.22 (0.78) −0.069 (0.063) −0.069 (0.061) 0.92
fS 6.97 (0.84) 6.32 (0.71) 7.03 (0.84) 6.39 (0.71) 6.82 (0.88) 6.12 (0.74) −0.061 (0.067) −0.074 (0.062) 0.090
cS 6.88 (0.63) 6.44 (0.76) 6.92 (0.63) 6.52 (0.80) 6.61 (0.70) 6.14 (0.87) −0.089 (0.088) −0.11 (0.071) 0.41
Values are means (standard deviations, in cm3) for the cross-sectional study sample at entry, and for the longitudinal study sample at entry and at 4-year follow-up.
TIV, total intracranial volume; WB, whole brain volume (GM + WM); GM, gray matter volume; WM, white matter volume; HIP, hippocampus volume (left plus right).
Annual variation (in cm3/year) is the ratio of the difference between follow-up and entry volume values to the delay between follow-up and entry. nS, non-smokers;
fS, former smokers; cS, current smokers; p is for the comparison of annual variation of volumes between men and women (One-Way ANOVA).
(p < 10−4, in all cases). Regarding annualized variation of these
phenotypes, we found significant loss of WB, GM, WM, and HIP
volumes in both men and women (p < 10−4, in all cases). Note
that, althoughmen and women did not significantly differ in their
annualized rate of WB loss, women exhibited significantly larger
annual loss of GM than men, while the opposite was found for
WM. However, there was no difference between men and women
in their annual rate of HIP volume loss.
EFFECT OF TOBACCO SMOKING ON BRAIN TISSUE VOLUMES
Whole brain
Table 4 reports the effects of tobacco smoking on WB volume,
effects size and post-hoc significance reported in Figure 1. Effect
on WB volume at entry failed to reach significance both in men
and in women (p = 0.057 and p = 0.12, respectively). The trend
observed in men was due to a lower WB volume in current
smokers compared to never smokers (p = 0.017, post-hoc test,
see Figure 1). There was no significant linear correlation between
WB volume and pack-years of men current smokers (regression
slope = −0.027, p = 0.64, N = 49).
The annualized rate of WB loss was significantly affected
by smoking status in men but not in women (p = 0.034 and
p = 0.12, respectively), although both groups exhibited simi-
lar profiles (see Figure 2). In men, current smokers exhibited
significantly higher WB rate of atrophy than both never smok-
ers and former smokers (p = 0.0094 and p = 0.031, respectively;
post-hoc t-test). However, there was no significant linear correla-
tion between WB rate of atrophy and pack-years in men current
smokers (p = 0.10).
Gray matter
Here, the patterns of smoking were very different between men
and women. Smoking was found to have a significant effect on
GM volume at entry in men but not in women (p = 0.039 and
p = 0.92, respectively, Table 5). Men who were current smokers
at the time of the study had a smaller GM volume than both
never smokers and former smokers (p = 0.011 and p = 0.047,
respectively, post-hoc t-tests, Figure 1), while there here was no
difference between the two latter groups (p = 0.23, post-hoc t-
test). The size of the effect of smoking in men (0.25 s.u. for
the difference between never smokers and current smokers) was
similar to that of age (0.25 s.u.) and much larger than those of
the other covariates (except TIV). Such reduction of GM vol-
ume in current smokers was not significantly correlated with their
pack-years (p = 0.64).
Meanwhile, we found that the annualized rate of loss of GM
was not modified by the participant smoking status, neither in
men (p = 0.57) nor in women (p = 0.55).
White matter
Smoking was found to have a significant effect on WM volume
at entry in women but not in men (p = 0.015 and p = 0.71,
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Table 4 | Cross-sectional and longitudinal analyses of tobacco smoking and other covariate effects on whole brain volume.
Cross-sectional analysis (entry time) Longitudinal analysis
Men Women Men Women
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status * 0.057 * 0.12 * 0.034 * 0.12
Age −0.19 <10−4 −0.26 <10−4 −0.016 0.77 0.098 0.011
ApoE-ε4† 0.081 0.061 −0.012 0.77 −0.10 0.39 −0.084 0.37
Alcohol −0.043 0.025 −0.025 0.12 0.023 0.66 0.076 0.041
BMI 0.011 0.58 0.023 0.18 0.045 0.40 0.0034 0.93
CES-D 0.032 0.088 −0.023 0.15 0.047 0.35 0.013 0.73
Cholesterolemia 0.0087 0.64 −0.030 0.065 −0.083 0.10 0.031 0.41
Education −0.070 0.0004 −0.036 0.038 −0.038 0.46 0.049 0.21
Glycaemia −0.077 <10−4 −0.023 0.17 −0.029 0.57 −0.10 0.009
MMSE −0.0024 0.90 −0.0031 0.86 −0.083 0.12 −0.00026 0.99
SBP −0.011 0.66 0.035 0.11 −0.0059 0.93 −0.076 0.14
DBP 0.0083 0.74 −0.018 0.41 −0.0031 0.97 0.082 0.10
WML −0.015 0.42 −0.010 0.54 0.0073 0.88 0.040 0.28
TIV 0.86 <10−4 0.83 <10−4 −0.17 0.0011 −0.13 0.0007
Effect size is in standardized unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D, Center
for epidemiological study depression scale; MMSE, mini-mental scale examination; WML, white matter lesion. TIV, total intracranial volume. *See Figures 1, 2;
†Effect size is carriers–non carriers. Bold values indicate effect significance level < 0.05.
FIGURE 1 | Size (and 95% confidence interval, in standardized unit (s.u.)
of the effects of smoking on cerebral phenotypes volumes at entry in
men (blue bars) and women (red bars). WB, whole brain volume (GM +
WM); GM, gray matter volume; WM, white matter volume; HIP, hippocampus
volume (left plus right). nS, non-smoker; fS, former smoker; cS, current
smokers. Significance level of post-hoc t-tests for the comparison between
subgroups of differing smoking status ∗p < 0.05; ∗∗p < 0.01;
†p < 0.001; ‡p < 0.0001.
respectively, Table 6). Women who were never smokers had a sig-
nificantly larger WM volume than current smokers (p = 0.020,
post-hoc t-test, Figure 1) while the difference with the former
smokers was close to significance (p = 0.055, post-hoc t-test). In
addition, the linear correlation between pack-years and WM vol-
ume at entry time in women who were either former or current
smokers was close to significance (regression slope = −0.077,
p = 0.062).
There was no effect of smoking on the annualized loss of WM
tissue, neither in men (p = 0.10) nor in women (p = 0.47).
Hippocampus
Smoking was found to have additional significant specific effects
on hippocampal volume in women but not in men (p = 0.028
and p = 0.89, respectively; Table 7). Specifically, former smoker
women had smaller HIP volume than never smokers (p = 0.008,
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FIGURE 2 | Size (and 95% confidence interval, in standardized unit (s.u.)
of the effects of smoking on cerebral phenotype annualized rates of
change in men (blue bars) and women (red bars). WB, whole brain
volume (GM + WM); GM, gray matter volume; WM, white matter volume;
HIP, hippocampus volume (left plus right). nS, non-smoker; fS, former
smoker; cS, current smokers. Significance level of post-hoc t-tests for the
comparison between subgroups of differing smoking status ∗p < 0.05;
∗∗p < 0.01; †p < 0.001; ‡p < 0.0001.
Table 5 | Cross-sectional and longitudinal analyses of tobacco smoking and other covariate effects on gray matter volume.
Cross-sectional analysis (entry time) Longitudinal analysis
Men Women Men Women
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status * 0.039 * 0.92 * 0.57 * 0.55
Age −0.25 <10−4 −0.35 <10−4 −0.062 0.25 0.072 0.066
ApoE-ε4† 0.13 0.025 −0.028 0.60 −0.15 0.20 −0.10 0.29
Alcohol −0.0078 0.76 −0.030 0.15 −0.053 0.30 0.079 0.036
BMI −0.013 0.62 −0.0072 0.74 0.0065 0.90 0.039 0.33
CES-D 0.00059 0.98 −0.037 0.083 0.097 0.059 0.028 0.46
Cholesterolemia −0.0079 0.75 −0.020 0.34 −0.083 0.10 0.062 0.10
Education −0.031 0.23 0.015 0.50 −0.020 0.70 0.020 0.61
Glycaemia −0.076 0.003 −0.028 0.20 −0.032 0.53 −0.079 0.043
MMSE 0.033 0.21 0.025 0.26 −0.087 0.10 −0.0037 0.92
SBP −0.015 0.65 0.043 0.14 0.025 0.73 −0.034 0.52
DBP −0.010 0.76 −0.032 0.26 −0.049 0.49 0.028 0.58
WML −0.092 0.0003 −0.090 <10−4 −0.034 0.51 0.00072 0.98
TIV 0.74 <10−4 0.65 <10−4 −0.18 0.001 −0.075 0.047
Effect size is in standardized unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D, Center
for epidemiological study depression scale; MMSE, mini-mental scale examination. WML, white matter lesion. TIV, total intracranial volume. * See Figures 1, 2;
† Effect size is carriers–non carriers. Bold values indicate effect significance level < 0.05.
post-hoc t-test; see Figure 1), while there was no difference
between current smokers and the two other subgroups (p = 0.56
and p = 0.43 for the comparison with non-smokers and for-
mer smokers, respectively, post-hoc t-test). In addition, a very
significant linear correlation was found between pack-years and
HIP volume at entry time in women who were former smokers
(regression slope = –0.17, p = 0.0014, N = 128, see Figure 3).
Regarding the annualized rate of HIP volume loss (cor-
rected for whole GM volume at entry), we found an effect
of smoking that was significant in women (p = 0.016) and
close to significance in men (p = 0.08). Post-hoc t-tests revealed
the same pattern for men and women (see Figure 2), namely
that the HIP volume annualized loss was larger for cur-
rent smokers than either for never smokers (p = 0.078 and
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Table 6 | Cross-sectional and longitudinal analyses of tobacco smoking and other covariate effects on white matter volume.
Cross-sectional analysis (entry time) Longitudinal analysis
Men Women Men Women
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status * 0.71 * 0.015 * 0.10 * 0.47
Age −0.11 <10−4 −0.11 <10−4 0.068 0.21 0.033 0.41
ApoE-ε4† 0.020 0.71 0.0060 0.90 0.084 0.48 0.026 0.79
Alcohol −0.069 0.004 −0.014 0.43 0.11 0.041 −0.0060 0.87
BMI 0.032 0.19 0.048 0.011 0.052 0.35 −0.048 0.23
CES-D 0.057 0.016 −0.0048 0.79 −0.076 0.15 −0.021 0.59
Cholesterolemia 0.023 0.32 −0.033 0.066 0.0084 0.87 −0.043 0.25
Education −0.095 <10−4 −0.079 <10−4 −0.023 0.67 0.038 0.34
Glycaemia −0.065 0.007 −0.013 0.48 0.0070 0.89 −0.027 0.50
MMSE −0.036 0.14 −0.030 0.11 0.014 0.80 0.0047 0.90
SBP −0.0050 0.88 0.020 0.42 −0.044 0.55 −0.055 0.29
DBP 0.025 0.43 −0.00028 0.99 0.068 0.35 0.070 0.17
WML 0.061 <10−4 0.071 <10−4 0.059 0.26 0.053 0.17
TIV 0.82 0.010 0.85 <10−4 0.019 0.72 −0.067 0.081
Effect size is in standardized unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D, Center
for epidemiological study depression scale; MMSE, mini-mental scale examination. WML, white matter lesion. TIV, total intracranial volume. * See Figures 1, 2;
† Effect size is carriers–non carriers. Bold values indicate effect significance level < 0.05.
Table 7 | Cross-sectional and longitudinal analyses of tobacco smoking and other covariate effects on hippocampus volume.
Cross-sectional analysis (entry time) Longitudinal analysis
Men Women Men Women
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status * 0.89 * 0.028 * 0.080 * 0.016
Age −0.12 0.0001 −0.15 <10−4 0.081 0.15 −0.11 0.009
ApoE–ε4† −0.13 0.047 −0.069 0.20 −0.20 0.094 −0.035 0.71
Alcohol −0.055 0.054 0.043 0.039 0.00001 0.99 0.051 0.17
BMI 0.049 0.098 0.022 0.31 0.067 0.21 −0.023 0.56
CES-D −0.052 0.065 −0.045 0.030 0.028 0.59 −0.035 0.35
Cholesterolemia −0.025 0.38 −0.025 0.22 −0.057 0.27 0.029 0.44
Education 0.029 0.31 −0.031 0.17 −0.025 0.63 −0.0070 0.86
Glycaemia −0.042 0.14 −0.019 0.36 0.029 0.58 0.064 0.097
MMSE −0.032 0.28 −0.00063 0.98 −0.037 0.49 −0.014 0.72
SBP 0.030 0.44 0.026 0.36 −0.044 0.55 0.067 0.19
DBP −0.0085 0.82 −0.034 0.24 0.065 0.37 0.00065 0.99
WML −0.043 0.13 −0.045 0.033 −0.043 0.40 −0.14 0.0003
GM 0.72 <10−4 0.71 <10−4 −0.11 0.055 −0.0085 0.84
Effect size is in standardized unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D,
Center for epidemiological study depression scale; MMSE, mini-mental scale examination. WML, white matter lesion. GM, gray matter volume. * See Figures 1, 2;
† Effect size is carriers–non carriers. Bold values indicate effect significance level < 0.05.
p = 0.0053, for men and women, respectively, post-hoc t-
tests) or for former smokers (p = 0.025 and p = 0.036, for
men and women, respectively, post-hoc t-tests). Such a larger
rate of HIP volume loss was not correlated with the current
smokers pack-years, either in men (p = 0.09) or in women
(p = 0.69).
Pooled analysis
Analysis of baseline volumes in the pooled sample of men and
women (see Table 8) revealed a significant effect of smoking on
WB and WM, but not on GM and HIP, current smokers hav-
ing significant lower WB and WM volumes than non-smokers
(volume difference = 0.13 s.u. in both cases, p = 0.004 and
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FIGURE 3 | Plot of the linear regression analysis of hippocampus
volume at study entry (residual values in standardized unit) as a
function of lifetime cumulative cigarette smoking (in pack-years:
number of packs smoked per day times number of years of smoking)
in former smoker women. Slope of the regression line: −0.17, p = 10−4,
N = 128.
p = 0.023, for WB and WM, respectively), and former smokers
having lower WB volume than non-smokers (volume difference
= 0.053 s.u., p = 0.046). There was a sex main effect on WB
and GM volumes, women having smaller TIV-corrected WB and
GM volumes than men (WB volume difference = 0.081 s.u.,
p = 0.043; GM volume difference = 0.12 s.u., p = 0.031). There
was no sex by smoking interaction on any baseline volume.
Regarding annualized rate of tissue volume losses (Table 9), we
found a significant effect of smoking for WB and HIP only: in
both cases, current smokers had increased rates of tissue loss when
compared to either never or former smokers (difference in rates of
WB volume loss = 0.34 and 0.45 s.u., respectively, p = 0.014 and
0.001, respectively; difference in rates of HIP volume loss = 0.45
s.u. in both cases, p = 0.001 in both cases). There was a sex main
effect on the annualized WB and GM volume loss, women having
larger rates of volume loss thanmen (difference in rates of volume
loss = 0.34 and 0.48 s.u., p = 0.005 and p < 10−4, respectively).
There was no sex by smoking interaction on any annualized tissue
volume loss.
Effects of covariates
At entry in the study, we found strong and significant effects
of age and TIV (resp. GM volume) on WB, GM, and WM vol-
umes (resp. HIP volume), both in men and in women (see
Figure 4 and Tables 4–7). TIV and age showed the largest effect
sizes of all covariates. On the contrary, age and TIV had much
smaller effects on annualized rates of brain tissue losses: signif-
icant TIV effects were observed on the annualized rates of WB
and GM in both sexes with a trend on HIP in men, whereas age
effect was significant only on the annualized rates of WB and
HIP loss in women with a trend on the GM volume in women
(see Figure 5). Interestingly, when significant, the size of tobacco
smoking effect was of the same order of magnitude as that of age
(see Figures 1, 4).
Other covariates had fewer, usually less significant, and smaller
effects than TIV and age.
WM lesion charge had similar effects in both sexes at entry in
the study: positive on WM volume and negative on GM volume,
resulting in no effect on WB volume. Regarding the annualized
rates of tissues losses, WML charge was negatively correlated with
the annualized rate of HIP volume loss.
Education negatively correlated with baseline WB and WM
volumes in men as well as in women (see Tables 4, 6), but had
no effect on annualized rates of tissue loss.
Male participants carrying ε4 allele(s) had significantly higher
baseline GM volumes than non-carriers, while having a reduced
HIP baseline volume.
In men, alcohol consumption was associated with reduced
baseline WB and WM volumes, while was positively associated
with the annualized rate ofWM loss. In women, alcohol increased
baseline HIP volume and reduced annualized WB and GM loss.
Glycaemia had significant negative effects on baseline WB,
GM, andWM volumes inmen but not in women. However, it was
associated with increased annualized WB and GM loss in women
only.
The other covariates either had very few and small sized effects
(BMI, CES-D) or no effect at all (MMSE, cholesterol, SBP and
DBPs).
Pooling men and women resulted in very similar results
regarding effects of covariates, the larger sample size helping
some effects reaching the 0.05 significance level (see for example
the negative effect of MMSE on baseline WM volume). In very
few cases, where the covariate had opposite effects in men and
women, discrepant results were observed between the pooled and
the stratified analyses (see for instance the effect of ApoE-e4 on
baseline GM volume, of alcohol on baseline HIP volume, or the
effect of age on the longitudinal analysis of WB volume changes).
DISCUSSION
In a large sample of healthy elderly participants, we have found
both sex-independent and sex-dependent effects of smoking on
brain atrophy. In men, we observed reduced GM volumes at base-
line and trends for increased annualized rate ofWM andHIP loss.
In women, we found reduced WM, and HIP volumes at baseline
and increased annualized rate of HIP loss.
METHODOLOGICAL ISSUES
We have identified in the literature five cohort studies that used
quantitative MRI for addressing the issue of tobacco-smoking
impact on brain aging in healthy elderly individuals (Enzinger
et al., 2005; Ikram et al., 2008; Debette et al., 2011; Durazzo et al.,
2012; Hoogendam et al., 2012, see Table 10). Before comparing
our findings with these previous reports, we think it is worth-
while listing the similarities and differences in the methodology
implemented in these studies and in ours.
Cohort study design
The present study was based on a design allowing investigation
of tobacco-related effects on atrophy both cross-sectionally in
1451 healthy older adults and longitudinally in 1111 of them
after 4 years. Two previous studies (Enzinger et al., 2005; Durazzo
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Table 8 | Cross-sectional analysis of tobacco smoking and other covariate effects on tissue volumes in the pooled sample of men and women.
WB GM WM HIP
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status 0.007 0.11 0.039 0.31
Sex * 0.081 0.043 0.12 0.031 0.034 0.47 −0.052 0.38
Smoking by sex 0.74 0.16 0.55 0.12
Age −0.19 <10−4 −0.28 <10−4 −0.089 <10−4 −0.12 <10−4
ApoE-ε4† 0.027 0.28 0.038 0.27 0.012 0.68 −0.095 0.013
Alcohol −0.036 0.002 −0.022 0.17 –0.044 0.002 −0.012 0.48
BMI 0.017 0.12 −0.0071 0.64 0.037 0.004 0.029 0.084
CES-D −0.0058 0.58 −0.024 0.095 0.012 0.32 −0.044 0.006
Cholesterolemia −0.012 0.26 −0.012 0.40 −0.0097 0.43 −0.022 0.16
Education −0.042 <10−4 −0.0033 0.83 −0.073 <10−4 −0.0042 0.80
Glycaemia −0.038 0.0004 −0.041 0.005 −0.030 0.018 −0.029 0.073
MMSE −0.0013 0.91 0.024 0.10 −0.025 0.048 −0.011 0.51
SBP 0.015 0.30 0.019 0.33 0.0088 0.61 0.023 0.30
DBP −0.0075 0.60 −0.023 0.23 0.0086 0.61 −0.019 0.38
WML −0.0091 0.38 −0.078 <10−4 0.057 <10−4 –0.041 0.009
TIV (‡SG) 0.89 <10−4 0.75 <10−4 0.89 <10−4 0.75‡ <10−4
WB, whole brain volume (GM + WM); GM, gray matter volume; WM, white matter volume; HIP, hippocampus volume (left plus right). Effect size is in standardized
unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D, Center for epidemiological study
depression scale; MMSE, mini-mental scale examination. WML, white matter lesion. TIV, total intracranial volume. * Effect size is men–women; † Effect size is
carriers–non carriers. ‡ SG used as a covariate instead of TIV. Bold values indicate effect significance level < 0.05.
Table 9 | Longitudinal analysis of tobacco smoking and other covariate effects on the annualized rate of tissue volume losses in the pooled
sample of men and women.
WB GM WM HIP
Effect size p-value Effect size p-value Effect size p-value Effect size p-value
Smoking status 0.005 0.23 0.12 0.004
Sex * 0.34 0.005 0.48 <10−4 −0.22 0.079 0.015 0.90
Smoking by sex 0.68 0.93 0.78 0.47
Age 0.064 0.039 0.034 0.28 0.038 0.22 −0.097 0.004
ApoE-ε4† −0.11 0.15 −0.14 0.065 0.049 0.51 −0.11 0.15
Alcohol 0.066 0.055 0.020 0.55 0.059 0.088 0.024 0.48
BMI 0.010 0.75 0.022 0.49 −0.017 0.59 0.0092 0.77
CES-D 0.021 0.50 0.046 0.14 −0.036 0.25 −0.020 0.52
Cholesterolemia −0.0060 0.84 0.011 0.71 −0.024 0.44 −0.0069 0.82
Education 0.015 0.63 0.0049 0.88 0.013 0.68 −0.012 0.71
Glycaemia −0.066 0.034 −0.054 0.082 −0.012 0.70 0.053 0.094
MMSE −0.026 0.41 −0.027 0.38 0.0041 0.90 −0.022 0.49
SBP −0.060 0.16 −0.020 0.64 −0.052 0.23 0.031 0.47
DBP 0.057 0.17 0.0060 0.89 0.068 0.11 0.019 0.64
WML 0.032 0.29 −0.0077 0.80 0.053 0.083 −0.10 0.0006
TIV (‡SG) −0.18 <10−4 −0.14 0.0002 −0.044 0.26 –0.056‡ 0.14
WB, whole brain volume (GM + WM); GM, gray matter volume; WM, white matter volume; HIP, hippocampus volume (left plus right). Effect size is in standardized
unit. P-value is the effect significance level. BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; CES-D, Center for epidemiological study
depression scale; MMSE, mini-mental scale examination. WML, white matter lesion. TIV, total intracranial volume. *Effect size is men—women; † Effect size is
carriers–non carriers. ‡ SG used as a covariate instead of TIV. Bold values indicate effect significance level < 0.05.
et al., 2012) used the same kind of design, albeit on much smaller
sample sizes (N = 186 including 144 at 2 year follow-up, and
N = 201 at baseline and follow-up, respectively); two others were
purely cross-sectional (Ikram et al., 2008; Hoogendam et al., 2012;
N = 3952 andN = 490, respectively) and one reported only lon-
gitudinal data (Debette et al., 2011;N = 1352; 6 years follow-up).
As regards the mean age of our sample, it falls within the range of
previous studies sample mean age [60, 76].
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FIGURE 4 | Size and 95% confidence interval, in standardized unit (s.u.)
of the effects of various covariates on cerebral phenotype volumes at
entry in men (blue bars) and women (red bars). WB, whole brain volume
(GM + WM); GM, gray matter volume; WM, white matter volume; HIP,
hippocampus volume (left plus right). BMI, body mass index; SBP and DBP,
systolic and diastolic blood pressure; CES-D, Center for epidemiological study
depression scale; MMSE, mini-mental scale examination. WML, white
matter lesion. TIV, total intracranial volume. Significance level of post-hoc
t-tests for the comparison between subgroups of differing smoking status
∗p < 0.05; ∗∗p < 0.01; †p < 0.001; ‡p < 0.0001.
Smoking consumption descriptors
All previous studies used categories similar to ours for describ-
ing the status of participants with respect to smoking, namely
never, former or current smoker at the time of their participation
in the study. In some studies, former smokers were pooled either
with current smokers (Enzinger et al., 2005; Durazzo et al., 2012)
or with non-smokers (Debette et al., 2011). With that respect,
it is important to note that the number of current smokers in
the (Durazzo et al., 2012) study was extremely small (5 to be
compared to 58 former smokers) so findings of this study really
concern former smokers which make them hardly comparable
with those of Debette et al. (2011) established in a sample of
197 current smokers. In addition, previous studies lack details on
individual smoking habits such as duration and quantity of smok-
ing (pack-years), or dates when former smokers quit smoking. As
amatter of fact, only one study (Durazzo et al., 2012) attempted at
testing a dose dependent relationship between smoking and brain
atrophy using lifetime smoking duration, a quantitative variable
related to the number of pack-years used in our study.
Cerebral phenotypes
Here, in addition to WB volume, we studied the effect of tobacco
separately for gray and WM, which has been done by only one of
the previous studies (Ikram et al., 2008), whereas others preferred
studying atrophy of either the WB volume (Enzinger et al., 2005;
Debette et al., 2011; Hoogendam et al., 2012) or of sets of ad’hoc
regions of interest (Durazzo et al., 2012). There are several reasons
why GM and WM should be studied separately. First, their life-
time course are very different (Good et al., 2001; Abe et al., 2010),
and some have suggested that their rate of atrophy during aging
are very different (Smith et al., 2007). Second, the cellular con-
tent and vascular fraction of the two tissues are very different
and one cannot thus a priori exclude the possibility of different
pathophysiological effects of tobacco in each tissue. Third, GM
and WM fraction are known to be different between men and
women (Allen et al., 2003; Lemaître et al., 2005b; Leonard et al.,
2008), which also calls for a separate analysis.
In addition to WB, GM, and WM we also investigated HIP
atrophy, a target area for age-related disorders that was also ana-
lyzed by Durazzo et al. (2012) and by Debette et al. (2011), the
latter using the temporal horn CSF volume as a surrogate marker
for HIP volume.
Taking into account sex confounding effects
We believe sex segregation to be desirable for studies dealing with
brain atrophy because of the potential confounding effect of sex
due to differences between men and women in lifestyle, includ-
ing tobacco consumption, and health parameters (Table 1). Such
differences have indeed been shown by others to have signifi-
cant sex-specific impact on brain aging in cognitively unimpaired
elderly individuals (Franke et al., 2014). Thanks to the large
sample size of the 3C-D-MRI cohort, we were able to assess
tobacco-smoking effects separately in men and in women, while
keeping high statistical power. Among previous studies, onemade
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FIGURE 5 | Size and 95% confidence interval, in standardized unit (s.u.) of
the effects of various covariates on cerebral phenotype annualized rates of
change in men (blue bars) and women (red bars).WB, whole brain volume
(GM + WM); GM, gray matter volume; WM, white matter volume; HIP,
hippocampus volume (left plus right). BMI, body mass index; SBP and DBP,
systolic and diastolic blood pressure; CES-D, Center for epidemiological study
depression scale; MMSE, mini-mental scale examination. WML, white matter
lesion. TIV, total intracranial volume. Significance level of post-hoc t-tests for
the comparison between subgroups of differing smoking status ∗p < 0.05;
∗∗p < 0.01; †p < 0.001; ‡p < 0.0001.
no mention at all of a sex effect (Enzinger et al., 2005), others
included a sex effect when analyzing atrophy but did not investi-
gate sex-dependent tobacco effects (Debette et al., 2011; Durazzo
et al., 2012; Hoogendam et al., 2012), and one specifically men-
tioned testing interaction between sex and tobacco effects but did
not report on it (Ikram et al., 2008). Actually, in the literature,
we found only one study reporting tobacco impacts separately
in men and in women, but the findings were based on a visual
grading of brain atrophy (Longstreth et al., 2000).
In the present study, sex-segregated analysis allowed uncover-
ing sex-specific of smoking on brain atrophy and notably that GM
(resp. WM) was primarily affected by smoking in men (resp. in
women). It also helped demonstrating that, despite similar trends,
quantitative effects of smoking could be quite different in men
and women, reaching significance in a subgroup but not in the
other.
EFFECT OF TOBACCO CONSUMPTION ONWHOLE BRAIN VOLUME
In our study, males who were still smoking after 65 had a strong
trend of reduced baseline WB volume as compared to never
smokers. This finding is in agreement with those of Ikram et al.
(2008) and Hoogendam et al. (2012) who reported reduced WB
volume in current smokers only. That such difference was not
found in other cross-sectional studies (Enzinger et al., 2005;
Durazzo et al., 2012) is likely to be due to the relatively small
sample size and consequent lack of statistical power of these latter
studies.
The present longitudinal analysis demonstrated that male cur-
rent smokers had a very significant increase in their annualized
rate of WB loss as compared to both never or former smok-
ers, consistent with the findings of the Debette et al. (2011)
study in which never and former smokers were pooled. Here,
in addition, we also demonstrate that former smokers did not
differ from never smokers in their WB rate atrophy, indicat-
ing that deleterious effects of smoking on brain atrophy stops
when individuals quit smoking. Again, we believe that absence
of similar findings in the Enzinger et al. (2005) longitudinal
study may be attributed to a lack of statistical power or to the
fact that they grouped former and current smokers in the same
group.
In women, we did not find significant effects of smoking on
WB baseline volume or annualized rate of loss. Here, a close look
at the profiles of WB volumes at study entry across smoking sta-
tus categories shows that effects of smoking on WB in women
followed the same pattern as in men, albeit with smaller ampli-
tude, but never reached significance. This is likely to be due to
smaller smoking duration and intensity in women as compared to
men, and also possibly to specific effects of hormone replacement
therapy on brain atrophy.
Note that pooling men and women would have led us to con-
clude for a sex-independent effect of smoking on WB volume
at study entry, similar what as reported by Ikram et al. (2008)
and Hoogendam et al. (2012) studies, and also on its annualized
rate of atrophy (Tables 8, 9). However, such pooling would have
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Table 10 | Main characteristics and findings of quantitative MRI past studies of tobacco-effects on brain atrophy.
Reference (cohort) Design (N, delay) Age Smoking status Brain phenotypes Main findings
Debette et al., 2011
(Framingham)
Long
(1352, 6.3 years)
61 nS + fS: 1155 (85%)
cS: 197 (15%)
GM + WM
THV
cS: increased annual loss
(resp. gain) in GM + WM
(resp. THV)
Durazzo et al., 2012
(ADNI)
Cross
(186)
76 nS: 118 (63%)
fS: 63 (34%)
cS: 5 (3%)
BREOS and AD ROIs cS + fS: smaller SFG
related to longer smoking
duration
Long
(144, 2 years)
nS: 92 (64%)
fS + cS: 52 (46%)
BREOS and AD ROIs
Other GM ROIs, GM
cS + fS: greater atrophy
rate smokers in BREOS
and AD ROIs, but not in
other GM ROI’s or whole
GM; greater loss in SFG
related to longer smoking
duration
Enzinger et al., 2005
(ASPS)
Cross
(201)
60 nS: 122 (61%)
fS + cS: 79 (39%)
GM + WM (in %TIV) No effect of smoking
Long
(201, 6 years)
No effect of smoking
Hoogendam et al., 2012
(Rotterdam)
Cross
(3962)
60 nS: 1154 (29%)
fS: 2076 (53%)
cS: 709 (18%)
GM + WM Reduced GM + WM
volume in cS but not in fS
Ikram et al., 2008
(Rotterdam)
Cross
(563)
73 nS: 211 (27%)
fS: 265 (54%)
cS: 87 (18%)
GM, WM, GM + WM Reduced GM + WM
volume in cS but not in fS
Design: study design (cross: Cross-sectional, Long: longitudinal), sample size (N) and delay between the first and last MRI exams (for longitudinal design, in years).
Age: mean participant’s age at their first MRI exam. Smoking status: nS, fS, cS: never, former, current smokers. Brain phenotypes: gray matter (GM) and white
matter (WM); THV, temporal horn volume; ROIs = regions of interest; BREOS, Brain Reward Executive Oversight System; AD, Alzheimer’s disease; SFG, superior
frontal gyrus.
concealed sex-dependent specific effects of smoking not only on
WB, but also on GM, WM, and HIP atrophy.
TISSUE- AND SEX-SPECIFIC EFFECTS OF SMOKING ON GRAY AND
WHITE MATTER VOLUMES
As a matter of fact, as opposed to WB volume, effects of smoking
on GM volume at entry time show distinct patterns between men
and women. Baseline GM volume was modified by smoking in
men, but not in women, the volume being lower in current smok-
ers than in former or non-smokers. On the contrary, baselineWM
volume was modified by smoking in women but not in men, the
volume being again lower in current smokers than in former or
never smokers. Among the five studies reported in Table 10, the
study by Ikram et al. (2008) was the only one that investigated
tissue-specific effects of smoking on baseline GM and WM vol-
umes, reporting no significant smoking effect and no interaction
between smoking and sex, only mentioning that “current smoking
was more related to total WM than GM.” There have been other
studies that investigated smoking effects on gray (Brody et al.,
2004; Gallinat et al., 2006; Fritz et al., 2014) or WM (Yu et al.,
2011; Fritz et al., 2014), but these studies reported effects on spe-
cific structures rather on whole tissue volumes. Thus, additional
studies are needed in order to confirm and explain this sex-related
difference in smoking effects on GM and WM. For both men
and women, effects of smoking on tissue volumes were appar-
ent in participants who were current smokers at the time of their
entry of the study whereas former smokers seemed to be free of
such tissue loss when compared to never smokers. Consequently
grouping former and current smokers as done in Durazzo et al.
(2012) and Enzinger et al. (2005) may have hidden those effects.
This effect of smoking on WB volume at entry in current smok-
ers only, also reported by others (Ikram et al., 2008; Hoogendam
et al., 2012), is likely to be due to the longer duration and larger
pack-years in the current smoker group, and suggests a dose
threshold of tobacco consumption for its deleterious effects to
take place.
Meanwhile, absence of smoking effect on the annualized GM
atrophy rate in either men or women is in agreement with the
only other similar report on this topic in which smoking status
was found to affect specific GM ROI’s but not GM as a whole
(Durazzo et al., 2012). As for the annualized WM volume loss
due to smoking, we observed a trend for a significant increase
in men current smokers only, but a similar pattern was also
observed in women. This suggests a possible effect in both sexes
and future studies should include WM in analyses to assess this
question.
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These findings should also be interpreted within the frame-
work of sexual brain dimorphism. In the present study, we found
between sex differences regarding both baseline volumes and their
rates of atrophy. Specifically, women exhibited larger WB annual-
ized rate of atrophy than men, a finding that, to our knowledge,
has never been reported before in such large sample of healthy
elderly.We think that drastic changes in circulating hormone con-
centrations due to menopause in women could be one cause of
such phenomenon. Indeed, a previous longitudinal study on a
small sample of elderly women has shown that women under hor-
mone replacement therapy (HRT) had smaller brain atrophy rates
than those who were not under HRT (Raz et al., 2004). This find-
ing was explained by the break in the neuroprotective effect of
estrogens at menopause on the brain of women that did not take
HRT (Gandy, 2003). In our study, more than 50% of the women
longitudinal sample (406 among the 721) never had HRT which,
we believe, explains in part the larger annualized rate of atrophy
observed in the entire sample of women as compared to men.
EFFECT OF TOBACCO CONSUMPTION ON HIPPOCAMPUS VOLUME
Baseline HIP volume was affected by smoking status in women
only, female former smokers having a lower HIP volume than
female never smokers. Moreover, a strong and very significant
negative correlation was found between the number of pack-years
and the HIP volume in female former smokers. Recall that in this
analysis, GM volume was used as a covariate. Accordingly, obser-
vation of an absence of effect in men means that smoking has
no specific effect on mean HIP as compared to its global effect
on GM. In women, we did not find a smoking effect on GM as
a whole: accordingly, observation of a smoking effect in women
HIP volume means that this area is a site of specific vulnerability
to tobacco smoking compared to global GM. To our knowledge,
such a result has never been reported. Smoking effects onHIP vol-
ume have been rarely reported, the study of Durazzo et al. (2012)
being the only one including the hippocampal area as an ROI of
interest. However, in this study there was no significant effect on
tobacco on baseline HIP, and a sex by smoking interaction was not
searched for. In a more recent study in a sample of 82 young-to-
middle-aged adults (Durazzo et al., 2013), the same authors did
report lower total HIP volume (and subfields volumes) in smok-
ers as compared to non-smokers but their sample included only 6
smoking womenwhich did not allow testing for a sex effect. Other
studies based on VBM (Brody et al., 2004; Gallinat et al., 2006; Yu
et al., 2011) did not report effect of smoking on the HIP, but they
were based on relatively small samples (N < 50) of younger par-
ticipants (including young and middle aged adults), and did not
search for a sex by smoking interaction.
As for the HIP annualized rate of atrophy, we observed a sig-
nificant and strong effect in women with a similar trend in men,
current smokers having larger rates of HIP loss, as compared to
both former or never smokers. This result is consistent with the
finding of Debette et al. (2011) of accelerated temporal horn vol-
ume increase in current smokers as opposed to never and former
smokers, as well as with the report of Durazzo et al. (2013) show-
ing larger rates of HIP loss in current smokers as compared to
non-smokers. It is however in partial disagreement with other
findings (Durazzo et al., 2012) reporting accelerated volume loss
of medial temporal GM structures in a group of 52 mainly former
smokers, whereas our study indicated no difference in HIP annu-
alized rate of atrophy between non and former smokers. We think
that methodological factors are likely to explain this discrepancy.
Overall, our results emphasize HIP as particularly vulnera-
ble to tobacco smoking, as it is to many adverse conditions
such as cerebral ischemia, epileptic seizures, and oxidative stress,
Wang and Michaelis (2010). Underlying mechanisms for such
vulnerability are not well-determined (particularly their causality
relationships), but reactive oxygen species known to be abundant
in the mainstream of cigarette smoke (Pryor et al., 1993), appear
to be potential candidates.
OTHER COVARIATES
As this paper focuses on tobacco smoking and atrophy, we will
briefly discuss the largest and most significant effects of these
covariates on brain atrophy. Besides, we previously reported else-
where on effects on brain atrophy of ApoE ε4 genotype (Lemaître
et al., 2005b; Crivello et al., 2010), depression (Elbejjani et al.,
2014), and WM lesion (Godin et al., 2009). Note also that, with
the exception of age and TIV, the size of effects of covariates were
usually smaller that those of smoking.
Alcohol
In our study, alcohol was associated with increased WB atrophy,
being significant on theWB andWM of men only. These findings
fit with previous reports showing alcohol detrimental effect on
brain tissue atrophy in both sexes (Hommer et al., 2001;Mukamal
et al., 2001; Demirakca et al., 2011), or more marked in men
than in women (Pfefferbaum et al., 2001; Anstey et al., 2006).
As regards to the HIP, the trend for increased atrophy associ-
ated to alcohol agrees with other studies (Harding et al., 1997;
Pfefferbaum et al., 2001; Anstey et al., 2006; Demirakca et al.,
2011). Note that in our study the effect was observed in men
only, which can be explained by the larger alcohol intake in men.
Actually, womenwere found to have reducedHIP atrophy as com-
pared to global GM, which may be mediated by the reduction
of cardiovascular risk factors in low level of alcohol intake indi-
viduals (Tolstrup et al., 2006). When pooling men and women,
our longitudinal analysis showed no significant effect of alcohol
intake on the annualized rate of brain atrophy, in apparent con-
tradiction with previous findings of accelerated brain atrophy in
heavy drinkers (Akiyama et al., 1997; Enzinger et al., 2005). We
think that this discrepant result is explained by the relatively low
alcohol intake in our cohort (1.5 and 0.5 drink per day in men
and women, respectively).
Glycaemia
In our study, increased glycaemia was associated with increased
atrophy of both gray and WM, the association being significant
in men only. These results are consistent with previous reports
enhanced atrophy of WB with increased glycaemia (Araki et al.,
1994; Ikram et al., 2008; Hoogendam et al., 2012) or percent-
age of glycated hemoglobin A (HbA1c) (Enzinger et al., 2005).
Longitudinally, we found higher glycaemia associated with a
larger rate of GM atrophy that was significant in women only, a
finding in line with that of another longitudinal study (Enzinger
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et al., 2005) reporting association a higher rate of brain atrophy
with HbA1c.
Body mass index
BMI was positively associated with WM volume, but not with
GM, the association being significant in women only. These find-
ings are in agreement with a previous report of increased WM
volume in obese adults, this effect being partially reversed by diet-
ing (Haltia et al., 2007). Absence of BMI effect on GM atrophy has
also been reported others (Haltia et al., 2007; Debette et al., 2014).
Note, however, that two recent studies reported discrepant results,
namely increase of the Brain Age score (an index of accelerated
cortical aging) with BMI especially in men (Franke et al., 2014),
reduced GM atrophy with increased BMI (Bobb et al., 2012). But
those differences might be explained by the covariates used in
both studies, especially with Bobb et al. (2012) which did not
include a sex effect.
As regards the longitudinal analyses, we did not find any
change in annualized rates of GM, WM or HIP loss, neither
in men nor in women. This is in agreement with the findings
reported by Debette et al. (2011), but others have reported par-
tially conflicting findings, namely increased rate of WB atrophy
with increased BMI (Enzinger et al., 2005) or reduced rate of WM
atrophy with increased BMI (Bobb et al., 2012).
Education
Education was negatively associated with WM, but not with GM,
in both sexes, in agreement with previous reports of higher edu-
cation individuals having increased sulcal CSF volume (Coffey
et al., 1999; Longstreth et al., 2000) and thinner cortex in tem-
poral, occipital and parietal areas as well as lower HIP volume
(Pillai et al., 2012). Education had, however, not effect on the
annualized rates of brain tissue loss. Our result thus argues in
favor of the hypothesis stating that education might influence
cognitive reserve through connectivity and/or synapses efficiency
rather than by neuron numbers.
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